Galderma, the brand behind fillers like Restylane, Dysport and Sculptra Aesthetic, announced today the FDA approval of two new fillers to the Restylane category: Restylane Refyne and Restylane Defyne.

Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year. The Food and Drug Administration (FDA) has approved Restylane ® Defyne ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

The Food and Drug Administration recently approved two new treatments to reduce the severity of nasolabial folds or “laugh lines” in adults. Restylane Refyne and Restylane Defyne are dermal fillers ...

Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, ...

Galderma, the company behind injectables like Restylane Refyne and Restylane Defyne, just announced its most surprising brand collaboration thus far, and we couldn’t be more into it. The partnership ...